Biogen (BIIB) capital expenditure was $185M in FY2025 (-48% YoY). The tables below show the complete quarterly and annual capital expenditure history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Capital Expenditure
Fiscal Year
Capital Expenditure
YoY
2025
$185M
-48%
2024
$360M
+16%
2023
$311M
+28%
2022
$243M
-12%
2021
$277M
-42%
2020
$477M
-29%
2019
$670M
-13%
2018
$774M
-58%
2017
$1.8B
+135%
2016
$785M
+20%
2015
$652M
+106%
2014
$316M
-91%
2013
$3.5B
+1279%
2012
$255M
+22%
2011
$208M
+20%
2010
$173M
+4%
2009
$166M
-40%
2008
$276M
-3%
2007
$284M
Recent Quarterly Capital Expenditure
Quarter
Capital Expenditure
Q1 2026
$51M
Q4 2025
$60M
Q3 2025
$52M
Q2 2025
$27M
Q1 2025
$47M
Q4 2024
$66M
Q3 2024
$130M
Q2 2024
$43M
Q1 2024
$121M
Q4 2023
$65M
Q3 2023
$88M
Q2 2023
$87M
Source: BIIB on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.